Specificity of anti-leukotriene actions of nicardipine

Allan M. Lefer, I. Leprán, David M. Roth, J. Bryan Smith

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

The calcium channel blocker, nicardipine (100 ng/ml) markedly antagonized the coronary vasoconstrictor effect of the peptide leukotrienes LTC4 and LTD4 on the isolated perfused cat coronary artery. However, nicardipine even at 300 ng/mi failed to antagonize the leukotriene induced contraction of either tracheal or pulmonary parenchymal strips from guinea pigs. However, at higher concentrations (i.e., 10 μg/ml), nicardipine inhibited the production of peptide leukotrienes from minced cat lung incubated in the presence of A23187. Thus, nicardipine exerts some selectivity in its anti-leukotriene actions.

Original languageEnglish
Pages (from-to)1141-1150
Number of pages10
JournalPharmacological Research Communications
Volume16
Issue number12
DOIs
Publication statusPublished - 1984

Fingerprint

Nicardipine
Leukotrienes
Cats
Leukotriene D4
Leukotriene C4
Lung
Peptides
Calcimycin
Calcium Channel Blockers
Vasoconstrictor Agents
Coronary Vessels
Guinea Pigs

ASJC Scopus subject areas

  • Pharmacology

Cite this

Specificity of anti-leukotriene actions of nicardipine. / Lefer, Allan M.; Leprán, I.; Roth, David M.; Smith, J. Bryan.

In: Pharmacological Research Communications, Vol. 16, No. 12, 1984, p. 1141-1150.

Research output: Contribution to journalArticle

Lefer, Allan M. ; Leprán, I. ; Roth, David M. ; Smith, J. Bryan. / Specificity of anti-leukotriene actions of nicardipine. In: Pharmacological Research Communications. 1984 ; Vol. 16, No. 12. pp. 1141-1150.
@article{6a1c41893d054dc18ae27355b13cab0d,
title = "Specificity of anti-leukotriene actions of nicardipine",
abstract = "The calcium channel blocker, nicardipine (100 ng/ml) markedly antagonized the coronary vasoconstrictor effect of the peptide leukotrienes LTC4 and LTD4 on the isolated perfused cat coronary artery. However, nicardipine even at 300 ng/mi failed to antagonize the leukotriene induced contraction of either tracheal or pulmonary parenchymal strips from guinea pigs. However, at higher concentrations (i.e., 10 μg/ml), nicardipine inhibited the production of peptide leukotrienes from minced cat lung incubated in the presence of A23187. Thus, nicardipine exerts some selectivity in its anti-leukotriene actions.",
author = "Lefer, {Allan M.} and I. Lepr{\'a}n and Roth, {David M.} and Smith, {J. Bryan}",
year = "1984",
doi = "10.1016/S0031-6989(84)80079-X",
language = "English",
volume = "16",
pages = "1141--1150",
journal = "Pharmacological Research",
issn = "1043-6618",
publisher = "Academic Press Inc.",
number = "12",

}

TY - JOUR

T1 - Specificity of anti-leukotriene actions of nicardipine

AU - Lefer, Allan M.

AU - Leprán, I.

AU - Roth, David M.

AU - Smith, J. Bryan

PY - 1984

Y1 - 1984

N2 - The calcium channel blocker, nicardipine (100 ng/ml) markedly antagonized the coronary vasoconstrictor effect of the peptide leukotrienes LTC4 and LTD4 on the isolated perfused cat coronary artery. However, nicardipine even at 300 ng/mi failed to antagonize the leukotriene induced contraction of either tracheal or pulmonary parenchymal strips from guinea pigs. However, at higher concentrations (i.e., 10 μg/ml), nicardipine inhibited the production of peptide leukotrienes from minced cat lung incubated in the presence of A23187. Thus, nicardipine exerts some selectivity in its anti-leukotriene actions.

AB - The calcium channel blocker, nicardipine (100 ng/ml) markedly antagonized the coronary vasoconstrictor effect of the peptide leukotrienes LTC4 and LTD4 on the isolated perfused cat coronary artery. However, nicardipine even at 300 ng/mi failed to antagonize the leukotriene induced contraction of either tracheal or pulmonary parenchymal strips from guinea pigs. However, at higher concentrations (i.e., 10 μg/ml), nicardipine inhibited the production of peptide leukotrienes from minced cat lung incubated in the presence of A23187. Thus, nicardipine exerts some selectivity in its anti-leukotriene actions.

UR - http://www.scopus.com/inward/record.url?scp=0021738412&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021738412&partnerID=8YFLogxK

U2 - 10.1016/S0031-6989(84)80079-X

DO - 10.1016/S0031-6989(84)80079-X

M3 - Article

VL - 16

SP - 1141

EP - 1150

JO - Pharmacological Research

JF - Pharmacological Research

SN - 1043-6618

IS - 12

ER -